Literature DB >> 16254671

Vena cava filters in cancer patients: experience with 50 patients.

Antonio Eduardo Zerati1, Nelson Wolosker, Guilherme Yazbek, Marcel Langer, Kenji Nishinari.   

Abstract

OBJECTIVE: To study the immediate and late results obtained from the implantation of vena cava filters in cancer patients with deep vein thrombosis concomitant with neoplasia.
METHODS: This was a retrospective evaluation of 50 patients with an association of cancer and deep venous thrombosis who underwent interruption of the inferior vena cava and the insertion of permanent vena cava filters. The indications for the procedure, filter implantation technique, early and late complications related to the operation, and the clinical evolution were evaluated.
RESULTS: The most frequent indication for filter implantation was the contraindication for full anticoagulant treatment (80%). The femoral vein was the preferred access route (86% of the patients). There were no complications related to the surgical procedure. During the follow-up, the following complications were observed: 1 episode of nonfatal pulmonary thromboembolism, 2 cases of occlusion of the inferior vena cava, and 1 case of thrombus retained in the device. Twenty patients (40%) died due to progression of the neoplasm.
CONCLUSIONS: Interruption of the inferior cava vein using an endoluminal filter is a procedure with a low rate of complications. It is a safe and efficient measure for preventing pulmonary embolism in cancer patients who have deep vein thrombosis of the lower limbs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254671     DOI: 10.1590/s1807-59322005000500003

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  5 in total

Review 1.  Using inferior vena cava filters to prevent pulmonary embolism.

Authors:  John Chung; Richard J T Owen
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

Review 2.  Venous thromboembolism in cancer patients: an underestimated major health problem.

Authors:  Jihane Khalil; Badr Bensaid; Hanan Elkacemi; Mohamed Afif; Younes Bensaid; Tayeb Kebdani; Noureddine Benjaafar
Journal:  World J Surg Oncol       Date:  2015-06-20       Impact factor: 2.754

3.  Temporal trends in vena cava filter implantation in public health system inpatients: an 11-year analysis of the largest city in Brazil.

Authors:  Dafne Braga Diamante Leiderman; Marcelo Fiorelli; Marcelo Passos Teivelis; Nickolas Stabellini; Edson Amaro; Nelson Wolosker
Journal:  J Vasc Bras       Date:  2022-04-05

4.  Is routine screening for silent pulmonary embolism justified in patients with deep vein thrombosis?

Authors:  Marcela Juliano Silva; Cynthia de Almeida Mendes; Sergio Kuzniec; Mariana Krutman; Nelson Wolosker
Journal:  J Vasc Bras       Date:  2021-06-25

5.  Incidence, diagnosis, treatment methods, and outcomes of clinically suspected venous thromboembolic disease in patients with COVID-19 in a quaternary hospital in Brazil.

Authors:  Marcela Juliano Silva Cunha; Carlos Augusto Ventura Pinto; João Carlos de Campos Guerra; Adriano Tachibana; Maria Fernanda Cassino Portugal; Leonardo José Rolim Ferraz; Nelson Wolosker
Journal:  J Vasc Bras       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.